What is Neuronetics's clinical services — operating income?

Neuronetics (STIM) reported clinical services — operating income of -$1.86M in Q1 2026.

How has Neuronetics's clinical services — operating income changed year-over-year?

Neuronetics's clinical services — operating income increased by 23.1% year-over-year, from -$2.41M to -$1.86M.

What does clinical services — operating income mean?

This metric measures the profitability of the clinical services segment after deducting both direct costs and allocated operating expenses. It is a key indicator of the segment's ability to generate sustainable earnings and contribute to the company's overall financial health.

Neuronetics STIM Clinical Services — Operating Income

Other segment segments

Medical Device

$1.34M+1,088%

Similar metrics at other companies

FTREClinical Services Segment — Operating Income (Loss)

-$3.4M+99.3%

FTREClinical Services Segment — Segment Operating Income

$21.85M-8.0%

FTREClinical Services Segment — Segment Operating Income

$29.4M+292%

NHCInpatient Services — Operating Income

$33.05M+1.2%

FTREClinical Services Segment — Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest

-$12.3M+97.8%

WUConsumer Services — Operating Income

$16.2M-40.2%

Other financials

Income statement

See full

Revenue$34.5M+7.8%

Gross profit$16.2M+2.6%

Operating income-$9.0M+18.3%

Net income-$10.8M+14.9%

EPS (diluted)-$0.16+23.8%

Balance sheet

See full

Cash & equivalents$13.2M-34.7%

Total debt$85.4M+3.5%

Total equity$13.3M-62.6%

Total assets$125.4M-11.7%

Cash flow

See full

Operating cash flow-$9.4M+44.6%

CapEx$197.0K-10.0%

Free cash flow-$9.6M+44.1%

Valuation

See full

Market cap$90.46M-59.6%

Enterprise value$162.64M-44.6%

P/S0.6×-1.4×

Profitability

See full

Gross margin48%-15.6pp

Operating margin-19.4%-6.9pp

Net margin-24.5%-8.7pp

FCF margin-9.4%-4.1pp

Returns & leverage

See full

Return on equity-152.4%-1.4pp

Debt / equity6.4×+4.1×

Current ratio1.7×-0.8×

Where this comes from

Reported directly by Neuronetics in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's clinical services — operating income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neuronetics's clinical services — operating income?: Neuronetics (STIM) reported clinical services — operating income of -$1.86M in Q1 2026.
How has Neuronetics's clinical services — operating income changed year-over-year?: Neuronetics's clinical services — operating income increased by 23.1% year-over-year, from -$2.41M to -$1.86M.
What does clinical services — operating income mean?: This metric measures the profitability of the clinical services segment after deducting both direct costs and allocated operating expenses. It is a key indicator of the segment's ability to generate sustainable earnings and contribute to the company's overall financial health.